![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 401/12 | |
A61K 31/519 | |||
A61P 35/00 |
(11) | Patento numeris | 2638030 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 11791110.7 |
Europos patento paraiškos padavimo data | 2011-11-09 | |
(97) | Europos patento paraiškos paskelbimo data | 2013-09-18 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2020-04-15 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2011/059890 |
Data | 2011-11-09 |
(87) | Numeris | WO 2012/064805 |
Data | 2012-05-18 |
(30) | Numeris | Data | Šalis |
412064 P | 2010-11-10 | US |
(72) |
CALIENNI, John Vincent, US
CHEN, Guang-Pei, US
GONG, Baoqing, US
KAPA, Prasad Koteswara, US
SAXENA, Vishal, US
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
Astex Therapeutics Limited, 436 Cambridge Science Park Milton Park Cambridge, Cambridgeshire CB4 0QA, GB |
(54) | SUCCINATE SALT OF 7-CYCLOPENTYL-2 -(5-PIPERAZIN-1-YL-PYRIDIN-2-YLAMINO)-7H-PYRROLO[2,3-D]PYRIMIDINE-6-CARBOXYLIC ACID DIMETHYLAMIDE AND PROCESSES OF MAKING THEREOF |
SUCCINATE SALT OF 7-CYCLOPENTYL-2 -(5-PIPERAZIN-1-YL-PYRIDIN-2-YLAMINO)-7H-PYRROLO[2,3-D]PYRIMIDINE-6-CARBOXYLIC ACID DIMETHYLAMIDE AND PROCESSES OF MAKING THEREOF |